אנ-כאב
trima israel pharmaceutical products maabarot ltd - diclofenac sodium - ג'ל - diclofenac sodium 1 %w/w - diclofenac - diclofenac - for local treatment of rheumatic diseases, pain and non-infected inflammation.
קראון מיקרו
perrigo israel agencies ltd - pancreatin 60.12 mg - gastro resistant pellets - multienzymes (lipase, protease etc.) - pancreatic exocrine insufficiency.
ניטרודרם 5 tts
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם tts 5
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם 10 tts
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם tts 10
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
פרסולאט 10
bayer israel ltd - nifedipine - טבליות בשחרור מושהה - nifedipine 10 mg - nifedipine - nifedipine - treatment of hypertension.
סילריל פלוס
unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.
ליויאל 2.5 מג
organon pharma israel ltd., israel - tibolone - טבליה - tibolone 2.5 mg - tibolone - tibolone - complaints resulting from the natural or artificial menopause. prevention of osteoporosis in estrogen deficiency states. treatment of estrogen deficiency symptoms in postmenopausal women.
מבטרה 10 מגמל תוך ורידי
roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu